Form 8-K - Current report:
SEC Accession No. 0001390478-20-000039
Filing Date
2020-11-13
Accepted
2020-11-13 16:37:05
Documents
2
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sls-20201113x8xk.htm 8-K 28453
2 EX-99.1 sls-20201113x8xkex991.htm EX-99.1 18929
  Complete submission text file 0001390478-20-000039.txt   48815
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 201312051
SIC: 2834 Pharmaceutical Preparations